173 related articles for article (PubMed ID: 25063429)
21. An ovine transgenic Huntington's disease model.
Jacobsen JC; Bawden CS; Rudiger SR; McLaughlan CJ; Reid SJ; Waldvogel HJ; MacDonald ME; Gusella JF; Walker SK; Kelly JM; Webb GC; Faull RL; Rees MI; Snell RG
Hum Mol Genet; 2010 May; 19(10):1873-82. PubMed ID: 20154343
[TBL] [Abstract][Full Text] [Related]
22. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
[TBL] [Abstract][Full Text] [Related]
23. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
24. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
25. Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates.
; Reid SJ; Patassini S; Handley RR; Rudiger SR; McLaughlan CJ; Osmand A; Jacobsen JC; Morton AJ; Weiss A; Waldvogel HJ; MacDonald ME; Gusella JF; Bawden CS; Faull RL; Snell RG
J Huntingtons Dis; 2013; 2(3):279-95. PubMed ID: 25062676
[TBL] [Abstract][Full Text] [Related]
26. Minipigs as a Large-Brained Animal Model for Huntington's Disease: From Behavior and Imaging to Gene Therapy.
Reilmann R; Schuldenzucker V
Methods Mol Biol; 2018; 1780():241-266. PubMed ID: 29856023
[TBL] [Abstract][Full Text] [Related]
27. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
29. Viral-mediated overexpression of mutant huntingtin to model HD in various species.
Ruiz M; Déglon N
Neurobiol Dis; 2012 Nov; 48(2):202-11. PubMed ID: 21889981
[TBL] [Abstract][Full Text] [Related]
30. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
[TBL] [Abstract][Full Text] [Related]
31. Memory deficits in the transgenic rat model of Huntington's disease.
Zeef DH; van Goethem NP; Vlamings R; Schaper F; Jahanshahi A; Hescham S; von Hörsten S; Prickaerts J; Temel Y
Behav Brain Res; 2012 Feb; 227(1):194-8. PubMed ID: 22101303
[TBL] [Abstract][Full Text] [Related]
32. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
[TBL] [Abstract][Full Text] [Related]
33. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
[TBL] [Abstract][Full Text] [Related]
34. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
35. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
[TBL] [Abstract][Full Text] [Related]
36. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study.
Reilmann R; Lippross V; Hölzner E; Gigengack F; Bohlen S; Kugel H; Deppe M; Osada N; Lücke M; Riess O; Nguyen HP; Von Hörsten S; Schäfers K; Schäfers M; Jacobs AH; Hermann S
J Huntingtons Dis; 2015; 4(1):37-47. PubMed ID: 26333256
[TBL] [Abstract][Full Text] [Related]
37. Mind the gap: models in multiple species needed for therapeutic development in Huntington's disease.
Howland DS; Munoz-Sanjuan I
Mov Disord; 2014 Sep; 29(11):1397-403. PubMed ID: 25155258
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
39. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
[TBL] [Abstract][Full Text] [Related]
40. Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington's disease.
Temel Y; Cao C; Vlamings R; Blokland A; Ozen H; Steinbusch HW; Michelsen KA; von Hörsten S; Schmitz C; Visser-Vandewalle V
Neurosci Lett; 2006 Oct; 406(1-2):138-41. PubMed ID: 16905252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]